Summary
Updated Aug 31, 2026
Husam Younis is Chief Scientific Officer of Atrium Therapeutics, Inc. (RNA). 1 SEC Form 4 filing on record, dated 22 April 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Husam Younis has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Husam Younis go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Most Active Insiders Right Now
Husam Younis has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- John Kristofer Galashan - $410.21M of LTH open-market activity in the last 90 days
- John G. Danhakl - $410.21M of LTH open-market activity in the last 90 days
- Mark A. Stevens - $407.10M of NVDA open-market activity in the last 90 days
- Xuning Wang - $401.19M of SN open-market activity in the last 90 days
- Fairmount Funds Management LLC - $399.66M of SYRE open-market activity in the last 90 days
- Andreas Bechtolsheim - $393.27M of ANET open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Husam Younis?
Husam Younis is a corporate insider, tracked as Chief Scientific Officer of Atrium Therapeutics, Inc. (RNA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Husam Younis last file a Form 4?
The only primary Form 4 on record is dated 22 April 2026.
Where can I see all of Husam Younis's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Husam Younis and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial